Home Dividends High Dividend Yield Latest Valuation: HCP (NYSE: HCP)

Latest Valuation: HCP (NYSE: HCP)


HCP is part of the REITs industry and real estate sector. The company CEO is Thomas M. Herzog. HCP Inc is a real estate investment trust. It invests in real estate serving the healthcare industry in the U.S. It acquires, develops, leases, manages and disposes of healthcare real estate and provides financing to healthcare providers.

Previous Intraday Trading Performance:

The HCP stock showed a previous change of -0.41% with an open at 31.21 and a close of 31.24. It reached an intraday high of 31.31 and a low of 30.94.

SeekingAlpha:  REIT ETFs That Can Help You Sleep Well At Night


The stock has a market cap of $14.9b with 477.5m shares outstanding, of which the float is 473.3m shares. Trading volume reached 2,287,963 shares compared to its average volume of 3,046,054 shares. Based on the current average volume and close price, the trading liquidity is good.

Historical Trading Performance:

Over the last five trading days, HCP shares returned 0.06% and in the past 30 trading days it returned 12.33%. Over three months, it changed 17.16%. In one year it has changed 38.13% and within that year its 52-week high was 31.65 and its 52-week low was 21.48. HCP stock is 45.44% above its 52 Week Low.

Our calculations show a 200 day moving average of 26.20 and a 50 day moving average of 29.36. Currently HCP stock is trading 19.25% above its 200 day moving average.

SeekingAlpha:  REIT ETFs That Can Help You Sleep Well At Night


The last annual fiscal EPS for the company was reported at 0.86 that ended on 31st of December 2017, which according to the previous close, that is a PE of 36.33. Based on 10 analyst estimates, the consensus EPS for the next quarter is 0.43. The TTM EPS is 1.87, which comes to a TTM PE of 16.71.

The following are the last four quarter reported earnings per share:
09-30-2018:  0.44
06-30-2018:  0.47
03-31-2018:  0.48
12-31-2017:  0.48

The dividend per share is currently 1.48, which is a dividend yield of 4.74%.

Base on our calculations, the intrinsic value per share is 25.82, which means it may be overvalued by -21.01%

Indicators to Watch:

Based on the latest filings, there is 132.90% of institutional ownership. Short-interest is 25,523,239, which is 5.35% of shares outstanding. The short-interest ratio or days-to-cover ratio is 6.61. This stock has a moderate level of short interest, but may still be a buying opportunity depending on other indicators.

The current calculated beta is 0.44

Business Wire:  HCA Healthcare Completes Purchase of Mission Health

Fundamental Indicators:

Based on last reported financials, the company’s return on equity is 3.20%, return on assets is 1.26%, profit margin is 17.64%, price-to-sales is 11.05 and price-to-book is 2.94.

Company Scores:

All scores are out of six:
 0  :Valuation Score
 0  :Past Performance Score
 1  :Financial Strength Score
 0  :Future Growth Score
 3  :Dividend Score
 0  :Overall Score

John Jones
Worked for several Wall Street firms: Salomon Smith Barney, UBS, and Charles Schwab. Has developed skills and gained extensive experience over the years that is used today to uncover winning penny stocks.Also was an attorney for small businesses in Scottsdale, Arizona. That experience and understanding of law provides a unique perspective and edge in discovering quality companies in various industries.